Ethics statements and facilities All experiments involving highly pathogenic avian influenza viruses, such as H5 and H7 viruses, as well as a human-transmissible strain (A/Sichuan/01/2009,

Study design This randomized, controlled, open-label, phase 2 clinical trial ‘Pharmacokinetics, Tolerability and Safety of Favipiravir and Ribavirin for the Treatment of Lassa Fever (SAFARI)’

Friday, May 15, 2026 A group of pediatric eye disease researchers supported by the National Institutes of Health (NIH) has launched an open-access tool designed

Thursday, May 14, 2026 NIH-funded study lays foundation for antibody-based measles treatment. Colorized transmission electron micrograph of a measles virus particle (red). Microscopy by

Removing N-glycosylation of the ZF2001 vaccine affects neutralizing antibody levels Neutralizing antibody titers in the serum of immunized mice are typically used to evaluate humoral

Study cohort Eligible individuals were males born between January 1, 1972, and May 1, 2008, who had been members of KPSC health plans continuously since

In this study, we parameterized 30 deterministic models for acyclic disease dynamics through a parameter-space search with the aim of identifying model structures and ranges

New G.1 lineage drives the outbreak in SLE To investigate the evolutionary relationship between SLE’s epidemic lineage and global MPXV diversity, we generated 338 high-quality

Tuesday, May 12, 2026 Comprehensive characterization of islet cells facilitated by national organ donation program. A National Institutes of Health (NIH)-funded study has identified key

Albert, J. et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous